project id: TCGA-UVM; case submitter id: TCGA-VD-A8KE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 8.9; age at index: 74; days to birth: -27290; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1938; age at diagnosis: 27290; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T2a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 821.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 609; days to sample procurement: 0; initial weight: 20.0; sample id: 35dfeb9d-1f64-4d51-b27a-24ad8aa3327b; sample submitter id: TCGA-VD-A8KE-01A; portion id: af6186e1-b9d5-487d-978a-2b5d4e61b01c; portion submitter id: TCGA-VD-A8KE-01A-11; slide id: e1611c2f-76e9-48e3-badf-fa5faa613746; slide submitter id: TCGA-VD-A8KE-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;